{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:21:18Z","timestamp":1769631678636,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.canep.2025.102832","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:13:46Z","timestamp":1746749626000},"page":"102832","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Identification of non-virologic risk factors for lymphoma after the first year of kidney transplant in adults: A retrospective analysis"],"prefix":"10.1016","volume":"97","author":[{"suffix":"Jr","given":"Alfonso H.","family":"Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amer","family":"Belal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisham","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhannad A.","family":"Leghrouz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kawther","family":"Alquadan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.canep.2025.102832_bib1","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1159\/000495081","article-title":"Trends in the causes of death among kidney transplant recipients in the United States (1996-2014)","volume":"48","author":"Awan","year":"2018","journal-title":"Am. J. Nephrol."},{"issue":"17","key":"10.1016\/j.canep.2025.102832_bib2","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.canep.2025.102832_bib3","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/j.ajkd.2021.01.015","article-title":"Posttransplant Lymphoproliferative Disorder Following Kidney Transplantation: A Review","volume":"78","author":"Sprangers","year":"2021","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.canep.2025.102832_bib4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.TP.0000144335.39913.5C","article-title":"Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases?","volume":"79","author":"Ghobrial","year":"2005","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.canep.2025.102832_bib5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ajh.21911","article-title":"Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States","volume":"86","author":"Quinlan","year":"2011","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.canep.2025.102832_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2021.101391","article-title":"Association of HLA mismatch and MTOR inhibitor regimens with malignancy and mortality after kidney transplantation","volume":"66","author":"Santos","year":"2021","journal-title":"Transpl. Immunol."},{"issue":"3","key":"10.1016\/j.canep.2025.102832_bib7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s40266-024-01100-5","article-title":"Impact of Immunosenescence in Older Kidney Transplant Recipients: Associated Clinical Outcomes and Possible Risk Stratification for Immunosuppression Reduction","volume":"41","author":"Jallah","year":"2024","journal-title":"Drugs Aging"},{"key":"10.1016\/j.canep.2025.102832_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11899-013-0162-5","article-title":"Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies","volume":"8","author":"Al-Mansour","year":"2013","journal-title":"Curr. Hematol. Malig. Rep."},{"issue":"2","key":"10.1016\/j.canep.2025.102832_bib9","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/TP.0b013e3182200e8a","article-title":"Racial variation in the development of posttransplant lymphoproliferative disorders after renal transplantation","volume":"92","author":"Nee","year":"2011","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.canep.2025.102832_bib10","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1200\/JCO.2010.30.1515","article-title":"Racial differences in chronic immune stimulatory conditions and risk of non-Hodgkin's lymphoma in veterans from the United States","volume":"29","author":"Koshiol","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canep.2025.102832_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.21037\/aol.2017.11.01","article-title":"Disparities in lymphoma on the basis of race, gender, HIV status, and sexual orientation","volume":"1","author":"Becnel","year":"2017","journal-title":"Ann. Lymphoma"},{"issue":"24","key":"10.1016\/j.canep.2025.102832_bib12","first-page":"00170","article-title":"The Impact of Induction Therapy on the Risk of Post-Transplant Lymphoproliferative Disorder in Adult Kidney Transplant Recipients with Donor-Recipient Serological Epstein-Barr Virus Mismatch","volume":"S1600-6135","author":"Attieh","year":"2024","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.canep.2025.102832_bib13","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41568-018-0074-8","article-title":"mTOR signalling and cellular metabolism are mutual determinants in cancer","volume":"18","author":"Mossmann","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.canep.2025.102832_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000236781","article-title":"Glucocorticoid-induced apoptosis of lymphoid cells","volume":"105","author":"Schwartzman","year":"1994","journal-title":"Int Arch. Allergy Immunol."},{"key":"10.1016\/j.canep.2025.102832_bib15","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1097\/TP.0000000000000375","article-title":"The risk of cancer in recipients of living-donor, standard and expanded criteria deceased donor kidney transplants: a registry analysis","volume":"98","author":"Ma","year":"2014","journal-title":"Transplantation"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187778212500092X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187778212500092X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T08:26:03Z","timestamp":1769588763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187778212500092X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":15,"alternative-id":["S187778212500092X"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2025.102832","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of non-virologic risk factors for lymphoma after the first year of kidney transplant in adults: A retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2025.102832","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102832"}}